Ensysce Biosciences (ENSC) Earnings Analysis

Ensysce Biosciences (ENSC) next reports earnings on 2026-08-12, consensus EPS -0.5 USD. Last quarter (2026-05-15) it beat with EPS -0.52 USD vs -0.73 USD est (+28.8%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.08.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ENSC next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.5 USD
Revenue estimate0.00B

ENSC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.52 USD-0.73 USD+28.8%Beat
2026-03-30-0.75 USD-1.26 USD+40.5%Beat
2025-11-14-1.29 USD-0.85 USD-51.8%Miss
2025-08-13-0.79 USD-1.02 USD+22.5%Beat
2025-03-10-2.9 USD-2.74 USD-5.8%Miss
2024-08-14-3.3 USD-5.85 USD+43.6%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

ENSC valuation and analyst view

Trailing P/E-0.08
Trailing EPS-1.72333 USD
Price / book-5.70
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Ensysce Biosciences (ENSC)'s next earnings date?

Ensysce Biosciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.5 USD and revenue estimate of 0.00B.

Did ENSC beat earnings last quarter?

In its 2026-05-15 report, ENSC posted EPS of -0.52 USD versus a -0.73 USD estimate — a beat of 28.8%.

What is ENSC's earnings track record?

Over the last 6 reported quarters with consensus data, ENSC beat estimates 4 times (67%).

What is ENSC's current P/E ratio and EPS?

ENSC trades at a trailing P/E of -0.08 on trailing EPS of -1.72333360382549 USD.

What do analysts rate ENSC?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).